Daparyl VM 5mg/500mg/100mg Tablet SR
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Dapagliflozin (5mg) + Metformin (500mg) + Vildagliptin (100mg)
Overview Daparyl VM 5mg/500mg/100mg Tablet SR
Glynase-Met XR 5mg/500mg/100mg extended-release tablets are a triple-combination medication managing blood glucose. This medication, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It facilitates efficient insulin use, thus reducing blood sugar. Glynase-Met XR 5mg/500mg/100mg extended-release tablets are optimally ingested with meals. Dosage is determined by your physician; discontinue only under their guidance. Abrupt cessation may elevate blood sugar, risking serious complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Common adverse reactions include vaginal candidiasis, upper respiratory infection, cystitis, diarrhea, cephalalgia, nausea, and emesis. Adequate hydration helps prevent dehydration. Practicing good hygiene minimizes genital fungal infections. Prior to commencing Glynase-Met XR 5mg/500mg/100mg extended-release tablets, inform your doctor of any renal or hepatic dysfunction, urinary tract infections, or diuretic use. Pregnant or lactating individuals should seek medical advice before use. Limit alcohol consumption as it may heighten the incidence of certain side effects. Regular blood glucose monitoring is crucial.
Uses of Daparyl VM 5mg/500mg/100mg Tablet SR
Managing type 2 diabetes
Major Benefits of Daparyl VM 5mg/500mg/100mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Daparyl VM 5mg/500mg/100mg Sustained-Release Tablets should be administered with a meal.
Common Side effects of Daparyl VM 5mg/500mg/100mg Tablet SR:
- Vaginal yeast infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Diarrhea
- Headache
- Nausea
- Vomiting
How to use Daparyl VM 5mg/500mg/100mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume Daparyl VM 5mg/500mg/100mg Sustained-Release tablets with food.
How Daparyl VM 5mg/500mg/100mg Tablet SR works:
Daparyl VM 5mg/500mg/100mg Extended-Release Tablets contain three anti-hyperglycemic agents. Dapagliflozin enhances glucose elimination via the kidneys, consequently lowering blood glucose. Vildagliptin regulates blood sugar by boosting incretin hormones, prompting the pancreas to secrete more insulin and suppressing hepatic glucose production when blood sugar is elevated. Metformin reduces intestinal glucose absorption, inhibits hepatic glucose release, and improves insulin sensitivity, thereby managing blood glucose levels.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Daparyl VM 5mg/500mg/100mg SR tablets with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Daparyl VM 5mg/500mg/100mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks before prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Daparyl VM 5mg/500mg/100mg tablet likely poses a risk to breastfeeding infants. Scant evidence from human studies indicates potential drug transfer via breast milk, possibly resulting in infant harm.
DrivingCONSULT YOUR DOCTOR
The effect of Daparyl VM 5mg/500mg/100mg Tablet SR on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Daparyl VM 5mg/500mg/100mg sustained-release tablets are considered safe for patients with renal impairment. No dosage modification is necessary for this medication in such individuals.
LiverUNSAFE
Use of Daparyl VM 5mg/500mg/100mg SR tablets is likely contraindicated for individuals with hepatic impairment and should be avoided. Seek medical advice before using this medication.
What if you forget to take Daparyl VM 5mg/500mg/100mg Tablet SR :
Should you forget a Daparyl VM 5mg/500mg/100mg SR tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Daparyl VM 5mg/500mg/100mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |





